StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.02 (-11.19%)

Close on Nov 16, 2026Market cap $466.42KP/E –Yield –

Arcadia Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Arcadia Biosciences's enterprise value was -$3.66M on Nov 11, 2026, against -$975.25K a year earlier. Over the last 5 years it ranged from -$19.80M to $5.83M, with a median of -$3.83M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$3.66M–
2025Dec 31, 2025-$3.18M-332.5%
2024Dec 31, 2024$1.37M–
2023Dec 29, 2023-$12.36M–
2022Dec 30, 2022-$16.09M–
2021Dec 31, 2021-$11.96M-156.5%
2020Dec 31, 2020$21.18M+22.5%
2019Dec 31, 2019$17.29M–
2018Dec 31, 2018-$9.46M–
2017Dec 29, 2017-$3.96M-132.7%
2016Dec 30, 2016$12.11M-84.6%
2015Dec 31, 2015$78.76M–

More Arcadia Biosciences figures

See a number that looks wrong?